Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by Don2018on Oct 18, 2019 5:55pm
121 Views
Post# 30245854

RE:RE:Rodan + Fields: Putting customers first

RE:RE:Rodan + Fields: Putting customers first
wexworth wrote:

The key point we should take away, and they say it, their bar for product effectiveness is extremely high and their company success is foundational upon this bar being set so high. 

What is even more encouraging for Sirona is that Rodan and Fields has signalled to them that they are looking forward to working on other collaborations together. That tells me they have quite a bit of confidence in the foundational science, the team, and see forward possibilities. 

Sirona is clearly in a new league now, and I am really looking forward to the short, medium and longer term. Rodan had 7 employees in 2008. Enough said. 



I have to agree with your sentiment regarding R&F. They wouldn't risk their reputation with a company and/or product they didn't believe in. So their endorsement of SBM is a big deal, a very big deal.
Now we just have to figure out why the people who exercised all of those options could be selling into the open market. That is what may be keeping a lid on the share price, not the TA clown's dumb "analysis".
JMO
Bullboard Posts